154 related articles for article (PubMed ID: 38013124)
1. In vitro biodistribution studies on clinically approved FGFR inhibitors ponatinib, nintedanib, erlotinib and the investigational inhibitor KP2692.
Dömötör O; Mathuber M; Kowol CR
Eur J Pharm Sci; 2024 Jan; 192():106651. PubMed ID: 38013124
[TBL] [Abstract][Full Text] [Related]
2. Comparative studies on the human serum albumin binding of the clinically approved EGFR inhibitors gefitinib, erlotinib, afatinib, osimertinib and the investigational inhibitor KP2187.
Dömötör O; Pelivan K; Borics A; Keppler BK; Kowol CR; Enyedy ÉA
J Pharm Biomed Anal; 2018 May; 154():321-331. PubMed ID: 29567575
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of In Vitro Distribution and Plasma Protein Binding of Selected Antiviral Drugs (Favipiravir, Molnupiravir and Imatinib) against SARS-CoV-2.
Dömötör O; Enyedy ÉA
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769193
[TBL] [Abstract][Full Text] [Related]
4. Effect of Plasma Protein Binding on the Pharmacokinetics of Erdafitinib: Results of an Integrated Cross-Study Analysis.
Li LY; Guo Y; Gonzalez M; Ouellet D
J Clin Pharmacol; 2020 Mar; 60(3):391-399. PubMed ID: 31602692
[TBL] [Abstract][Full Text] [Related]
5. Studies of binding by 2-imidazolines to human serum albumin and alpha
Woolfork AG; Suh K; Weigand M; Hage DS
J Pharm Biomed Anal; 2021 Aug; 202():114135. PubMed ID: 34022667
[TBL] [Abstract][Full Text] [Related]
6. The role of fibroblast growth factor receptor (FGFR) protein-tyrosine kinase inhibitors in the treatment of cancers including those of the urinary bladder.
Roskoski R
Pharmacol Res; 2020 Jan; 151():104567. PubMed ID: 31770593
[TBL] [Abstract][Full Text] [Related]
7. Nanoformulations of anticancer FGFR inhibitors with improved therapeutic index.
Kallus S; Englinger B; Senkiv J; Laemmerer A; Heffeter P; Berger W; Kowol CR; Keppler BK
Nanomedicine; 2018 Nov; 14(8):2632-2643. PubMed ID: 30121385
[TBL] [Abstract][Full Text] [Related]
8. Analysis of free drug fractions in serum by ultrafast affinity extraction and two-dimensional affinity chromatography using α1-acid glycoprotein microcolumns.
Bi C; Zheng X; Hage DS
J Chromatogr A; 2016 Feb; 1432():49-57. PubMed ID: 26797422
[TBL] [Abstract][Full Text] [Related]
9. Characterization of drug binding with alpha
Beeram SR; Zhang C; Suh K; Clarke WA; Hage DS
J Chromatogr A; 2021 Jul; 1649():462240. PubMed ID: 34034105
[TBL] [Abstract][Full Text] [Related]
10. Ponatinib (AP24534), a multitargeted pan-FGFR inhibitor with activity in multiple FGFR-amplified or mutated cancer models.
Gozgit JM; Wong MJ; Moran L; Wardwell S; Mohemmad QK; Narasimhan NI; Shakespeare WC; Wang F; Clackson T; Rivera VM
Mol Cancer Ther; 2012 Mar; 11(3):690-9. PubMed ID: 22238366
[TBL] [Abstract][Full Text] [Related]
11. Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancer.
Englinger B; Kallus S; Senkiv J; Heilos D; Gabler L; van Schoonhoven S; Terenzi A; Moser P; Pirker C; Timelthaler G; Jäger W; Kowol CR; Heffeter P; Grusch M; Berger W
J Exp Clin Cancer Res; 2017 Sep; 36(1):122. PubMed ID: 28882160
[TBL] [Abstract][Full Text] [Related]
12. In vitro, in silico and integrated strategies for the estimation of plasma protein binding. A review.
Lambrinidis G; Vallianatou T; Tsantili-Kakoulidou A
Adv Drug Deliv Rev; 2015 Jun; 86():27-45. PubMed ID: 25819487
[TBL] [Abstract][Full Text] [Related]
13. Unique Hydrolysis of an Ester-Type Prodrug of Levodopa in Human Plasma: Relay-Type Role Sharing between Alpha-1 Acid Glycoprotein and Human Serum Albumin.
Kono K; Fukuchi Y; Okawa H; Nunoya KI; Imawaka H; Watanabe H; Maruyama T
Mol Pharm; 2019 Oct; 16(10):4131-4138. PubMed ID: 31433646
[TBL] [Abstract][Full Text] [Related]
14. Probing the combination of erlotinib hydrochloride, an anticancer drug, and human serum albumin: Spectroscopic, molecular docking, and molecular dynamic analyses.
Shahraki S; Razmara Z; Delarami HS; Poorsargol M
Luminescence; 2023 Jun; 38(6):772-782. PubMed ID: 37060304
[TBL] [Abstract][Full Text] [Related]
15. Enantioselective retention of beta-blocking agents on human serum albumin and alpha 1-acid glycoprotein HPLC columns: relationships with different scales of lipophilicity.
Barbato F; Carpentiero C; Grumetto L; La Rotonda MI
Eur J Pharm Sci; 2009 Dec; 38(5):472-8. PubMed ID: 19778607
[TBL] [Abstract][Full Text] [Related]
16. Contribution of alpha 1-acid glycoprotein to plasma protein binding of some basic antimicrobials in pigs.
Son DS; Hariya S; Shimoda M; Kokue E
J Vet Pharmacol Ther; 1996 Jun; 19(3):176-83. PubMed ID: 8803875
[TBL] [Abstract][Full Text] [Related]
17. High performance affinity chromatography (HPAC) as a high-throughput screening tool in drug discovery to study drug-plasma protein interactions.
Vuignier K; Guillarme D; Veuthey JL; Carrupt PA; Schappler J
J Pharm Biomed Anal; 2013 Feb; 74():205-12. PubMed ID: 23245252
[TBL] [Abstract][Full Text] [Related]
18. Comparison between immobilized artificial membrane (IAM) HPLC data and lipophilicity in n-octanol for quinolone antibacterial agents.
Barbato F; Cirocco V; Grumetto L; Immacolata La Rotonda M
Eur J Pharm Sci; 2007 Aug; 31(5):288-97. PubMed ID: 17540545
[TBL] [Abstract][Full Text] [Related]
19. Biomolecular interactions and binding dynamics of tyrosine kinase inhibitor erdafitinib, with human serum albumin.
Amir M; Qureshi MA; Javed S
J Biomol Struct Dyn; 2021 Jul; 39(11):3934-3947. PubMed ID: 32448054
[TBL] [Abstract][Full Text] [Related]
20. Drug likeness prediction of 5-hydroxy-substituted coumarins with high affinity to 5-HT
Żołek T; Enyedy ÉA; Ostrowska K; Pósa V; Maciejewska D
Eur J Pharm Sci; 2018 Mar; 115():25-36. PubMed ID: 29309875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
